HC pushes for approval of Liner accelator at GMC Nagpur

Published On 2025-05-12 10:38 GMT   |   Update On 2025-05-12 10:38 GMT

Bombay High Court

Nagpur: Following the delay over the lack of cancer treatment infrastructure in the state, the Maharashtra government has informed the Nagpur bench of the Bombay High Court that it will issue fresh administrative approval within three weeks for the long-pending installation of a linear accelerator machine at the Government Medical College and Hospital (GMCH), Nagpur, regardless of the increased costs. 

Advertisement

According to the news reports, a division bench comprising Justices Avinash Gharote and Abhay Mantri directed the Medical Education and Drugs Department, GMCH Dean, and the Maharashtra Medical Goods Procurement Authority to begin the procurement process immediately and to complete it within four weeks of receiving administrative clearance. The court emphasized that procurement orders must be placed immediately upon receiving administrative approval.

Medical Dialogues had previously reported that, granting relief to the Government Medical College and Hospital (GMCH), the Nagpur bench of the Bombay High Court recently stayed the National Medical Commission's (NMC) order of halting admissions to five seats in the MD (Radiation Oncology) course. The Apex Medical Commission had halted the admissions due to infrastructural deficiencies such as a non-functioning Brachytherapy machine and the absence of a linear accelerator, which was under procurement.

Also Read: HC Stays NMC Order to halt MD Radiation Oncology Admissions at GMCH Nagpur, Lauds AIIMS for Helping institute

As per recent media reports by TOI, "This has already dragged on too long without any tangible outcome," the bench remarked, while directing authorities to also apply for all necessary licences from competent authorities within a week to avoid further procedural delays.Additional Government Pleader Deepak Thakare submitted a letter from the state dated May 6, stating that a new administrative nod would be issued within three weeks. "Whatever the cost may be, a new administrative approval for installation of the linear accelerator will be issued within the stipulated time," he told the court.

The linear accelerator machine, vital for modern radiation therapy in cancer treatment, was originally sanctioned at a cost of ₹23.20 crore. However, with a 35% tax imposed by the Central Government, the final cost surged to approximately ₹45 crore.

During an earlier hearing, court directed the state government to allocate an additional ₹25 crore to cover the funding shortfall.

The court also noted the disparity in healthcare access, pointing out that while Chhatrapati Sambhaji Nagar GMCH has two such machines, Nagpur lacks even one—significantly impacting cancer patients in the region.

Also Read: HC orders ESIC Hospital Andheri Completion by August 15

According to TOI, in the last hearing, the Nagpur district administration informed that it was unable to arrange the additional Rs 25 crore required for the procurement of a linear accelerator for the Government Medical College and Hospital (GMCH). This was due to the exhaustion of available funds and an escalation in equipment costs.

The court proceedings saw Senior Advocate Firdos Mirza appearing for the state, Anup Gilda assisting as amicus curiae, and Advocate Sudhir Puranik representing the Nagpur Metropolitan Region Development Authority (NMRDA). The matter has been posted for next hearing on June 10.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News